News
By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...
The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...
Supplements of turmeric, or its active component curcumin, may help people with prediabetes or type 2 diabetes lose weight, ...
It's called Recursion OS. Using 36 petabytes (36 million gigabytes) of biological and chemical data, Recursion OS can ...
A newly uncovered U.S. military report reveals that over 400 Japanese were mobilized to run the Class-B and C Yokohama war ...
CLOVIS, CA – Sports Central’s Dylan Morgan highlights the Clovis West Football program and how their young roster learned ...
1d
TipRanks on MSNH. Lundbeck A/S Advances Clinical Trial for Promising MSA Treatment
H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...
As part of the treatment trial, Jay does chemotherapy every other week for six months. Access to clinical trials is offered ...
The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results